Abstract
The transport of glutamate across the plasma membrane is coupled to the movement of cations (Na+, K+, and H+) that are necessary for glutamate uptake and transporter cycling as well as anions that are uncoupled from the flux of glutamate. Although the relationship between these coupled (stoichiometric) and uncoupled (anion) transporter currents is poorly understood, transporter-associated anion currents often are used to monitor transporter activity. To define the kinetic relationship between these two components, we have recorded transporter currents associated with stoichiometric and anion charge movements occurring in response to the rapid application of l-glutamate to outside-out patches from human embryonic kidney cells expressing GLT-1 transporters. Transporter-associated anion currents were approximately twice as slow to rise and decay as stoichiometric transport currents, but the presence of permeant anions did not slow transporter cycling. A kinetic model for GLT-1 was developed to simulate the behavior of both components of the transporter current and to estimate the capture efficiency of GLT-1. In this model the K+counter-transport step was defined as rate-limiting, consistent with the slowing of transporter cycling after the substitution of internal K+ with Cs+ or Na+. The model predicts that in physiological conditions ∼35% of GLT-1 transporters function as buffers, releasing glutamate back into the extracellular space after binding.
Glutamate transporters support the movement of glutamate across cell membranes. In the CNS this transport is necessary to remove the glutamate that is released during excitatory synaptic transmission, because glutamate is not subject to extracellular enzymatic degradation. The movement of glutamate into cells against a concentration gradient is achieved by harnessing energy stored in the electrochemical gradients for Na+, K+, and H+; the translocation of each molecule of glutamate is accompanied by the inward movement of 3 Na+ and 1 H+and the outward movement of 1 K+ (Zerangue and Kavanaugh, 1996; Levy et al., 1998), an unbalanced movement of charge that results in an inward current. In addition to this movement of coupled charges, glutamate transporters allow certain anions to flow across the membrane uncoupled from the movement of glutamate (Fairman et al., 1995; Wadiche et al., 1995a; Eliasof and Jahr, 1996). Because many more anions than coupled charges traverse the membrane during each cycle of transport, this feature has been exploited to resolve transporter currents in outside-out patches in which the density of transporters is too low to resolve reliably the currents mediated by the movement of coupled charges (Bergles and Jahr, 1997; Otis et al., 1997; Otis and Jahr, 1998; Wadiche and Kavanaugh, 1998; Mennerick et al., 1999). By combining outside-out patch recording with rapid solution exchange techniques, we and others have found that it is possible to record charge movements associated with discrete steps in the transport cycle, revealing the speed at which glutamate and ion binding occur and conformational changes in the protein are induced. However, relating anion-potentiated transporter currents to the movement of glutamate relies on detailed knowledge about the relationship between the movement of coupled and uncoupled charges during transport.
The flux of both anions and substrate appear to be catalyzed by the transporter itself, because both components are present when transporters are expressed heterologously. Nevertheless, although the binding of glutamate activates the anion conductance, accumulation of substrate is neither dependent on anions nor affected by the direction of anion flux (Wadiche et al., 1995a). Furthermore, like many other neurotransmitter transporters (Sonders and Amara, 1996), glutamate transporters allow anions to traverse the membrane in the absence of substrate (Bergles and Jahr, 1997; Wadiche and Kavanaugh, 1998). Once bound by glutamate, the two pathways for charge transfer appear closely coupled as both currents rise to a peak rapidly and decay to a steady-state level in the continued presence of substrate (Bergles and Jahr, 1997; Grewer et al., 2000; Otis and Kavanaugh, 2000). However, the relative kinetics of these two currents vary between transporters (Bergles and Jahr, 1997; Auger and Attwell, 2000; Grewer et al., 2000), consistent with the differences in anion permeability (Wadiche et al., 1995a) and unitary conductance (Larsson et al., 1996; Wadiche and Kavanaugh, 1998) between transporters.
GLT-1 transporters are responsible for the majority of glutamate uptake in the mammalian brain (Rothstein et al., 1996; Tanaka et al., 1997). To determine the relationship between the movement of anions and coupled charges through GLT-1 during glutamate transport, we measured the kinetics of glutamate-induced anion and coupled transporter currents in outside-out patches removed from human embryonic kidney (HEK) cells that expressed a high density of GLT-1 transporters.
MATERIALS AND METHODS
Cell culture. GLT-1 transporters were expressed heterologously in HEK 293 cells. We used a stably transfected inducible cell line in which expression of GLT-1 was controlled by the ecdysone promoter (Dunlop et al., 1999). Cells were maintained in DMEM with 10% fetal calf serum, 0.4 mg/ml G418 (Invitrogen, San Diego, CA), 0.4 mg/ml Zeocin (Invitrogen), and 1% penicillin/streptomycin (Invitrogen) in tissue culture flasks at 37°C with 5% CO2. To prepare cells for experiments, we plated them at a low density on glass coverslips coated with poly-l-lysine and collagen (Invitrogen), allowed them to grow for 1 d, and then exposed them to 10 μm ponasterone A (Invitrogen) for 18–24 hr before recording.
Outside-out patch recordings. Coverslips were transferred to a Plexiglas chamber mounted on a Zeiss FS1 fixed stage upright microscope equipped with differential interference contrast optics. Cells were superfused with artificial CSF (ACSF) consisting of (in mm): 160 NaCl, 2.5 KCl, 2.5 CaCl2, 1.3 MgCl, 10 HEPES, and 10 glucose, pH 7.2 (NaOH), 330 mOsm. Whole-cell recordings were made from HEK cells with the use of established techniques, using internal solutions of the following composition (in mm): 160 KA− (where A− corresponds to the anions gluconate, nitrate, or thiocyanate), 10 EGTA, 10 HEPES, and 1 MgCl2, pH 7.3. TEA (20 mm) was substituted for K-gluconate for the paired pulse recovery experiments shown in Figure 4 to reduce the noise associated with K+ channel gating. Holding potentials have been corrected for the different junction potentials of the internal solutions. Patch electrodes had resistances of 1.5–3 MΩ when filled with the internal solution. After the establishment of whole-cell configuration the pipette was pulled away slowly from the cell, resulting in the removal of a patch of membrane in the outside-out configuration. Patches were brought in front of a multibarreled glass flow pipe that had control and test solutions flowing out. The standard patch ACSF solution contained (in mm): 170 NaCl, 2.5 KCl, 2.5 CaCl2, 1.3 MgCl2, and 10 HEPES, pH 7.2 (NaOH), 330 mOsm. All solutions were made by using HPLC grade water and ultrapure salts. Reagents (agonists, antagonists, etc.) were added directly to this solution. Rapid exchange of the solution at the patch was achieved via the use of a piezoelectric bimorph (Tong and Jahr, 1994). Exchange times of <200 μsec (10–90%) were measured at the end of each recording by recording the junction current produced at the tip of the electrode by switching between solutions of different ionic strength. These “open tip” responses are displayed above each trace to indicate the duration of agonist/antagonist application. All responses were recorded at room temperature (22–24°C) at a membrane potential of −90 mV, unless otherwise noted. A range of glutamate concentrations was applied to patches by connecting a miniature manifold (Warner Instruments, Grand Haven, MI) to one barrel of the flow pipe.
Patch currents were recorded with an Axopatch 200A amplifier (Axon Instruments, Foster City, CA), filtered at 5 kHz, and digitized at 50 kHz by using programs written in Axobasic (Axon Instruments). Analysis was performed by using programs written in Axobasic or Origin (Microcal, Northampton, MA) software. Data are represented as ± SEM, unless otherwise noted. Rise time was calculated from 20 to 80% of the peak, and half-decay was measured from the peak to the steady-state level. Significance was measured with a Student'st test, and significance reflects a p value of <0.05. Sweeps are averages of 5–30 responses.
Modeling. A chemical-kinetic model of glutamate transport was constructed in the Simulation Control Program environment (Simulation Resources, Redlands, CA) to describe the behavior of GLT-1. This cyclical model incorporates the discrete binding of 3 Na+, H+, glutamate, and K+, as required by the known stoichiometry of transport (Zerangue and Kavanaugh, 1996), anion conducting states, and voltage-dependent transitions. The binding order of Na+ and glutamate incorporates the finding that at least one Na+ binds before glutamate and at least one Na+ binds after glutamate (Wadiche et al., 1995a; Watzke et al., 2001). We also place H+ translocation with glutamate and Na+ (Zerangue and Kavanaugh, 1996) as opposed to with the K+ translocation step (Auger and Attwell, 2000), because cysteine is transported as a neutral zwitterion (A. Tzingounis, personal communication). We have chosen to make the K+ translocation step rate-limiting, based on the work of Kanner (Kanner and Sharon, 1978;Kanner and Bendahan, 1982) and because of the dramatic slowing of the cycle when Cs+ or Na+ is substituted for internal K+ (see Results). The rates of the K+ translocation step were set by the paired pulse recovery times. Model parameters were adjusted to provide the best fit to a set of averaged transporter currents recorded under each of the conditions described. All simulations include all of the anion conducting states and, in addition, use the same rate constants except where rate changes are described explicitly in the text. Simulated transporter responses in the presence of permeant anions are in units of open probabilities; in the absence of anions, transporter responses are in units of amperes per single transporter.
RESULTS
GLT-1 expression in HEK cells
The charge movement initiated by the binding of glutamate to transporters is highly dependent on the species of ions present. Because of the presence of an associated anion conductance, transporter currents elicited by glutamate are much larger in the presence of chaotropic anions such as thiocyanate (SCN−) and nitrate (NO3−) (Fairman et al., 1995; Wadiche et al., 1995a; Eliasof and Jahr, 1996; Bergles and Jahr, 1997). Our initial experiments were performed in the presence of intracellular SCN− to maximize the size of the glutamate transporter current. l-Glutamate (10 mm) elicited large inward currents (peak amplitude, −206.2 ± 21.3 pA; n = 20) in patches from HEK 293 cells that were exposed to ponasterone A for >24 hr to induce the expression of GLT-1 (Fig.1A). In contrast,l-glutamate (10 mm) did not evoke currents in outside-out patches from cells that had not been exposed to ponasterone A (n = 5), indicating that the expression of endogenous glutamate transporters in this cell line was below the limit of detection of this technique (Dunlop et al., 1999). Glutamate transporter currents rose to a peak rapidly (20–80% rise time, 248 ± 10 μsec) and then decayed to a quasi-steady-state level in 1.7 ± 0.1 msec (half-decay time) in the continued presence of l-glutamate. With the removal of glutamate this current decayed to baseline with a biexponential decay (τ1 = 1.4 ± 0.11 msec, 74%; τ2 = 21.9 ± 2.1 msec). The kinetics of these transporter currents were dependent on the concentration of l-glutamate, with the rise and decay kinetics slower with lower concentrations ofl-glutamate (Fig. 1A). In addition, the EC50 ofl-glutamate was much lower when measured at the peak of the response (137.8 ± 11.8 μm;n = 9) than when measured at steady state (12.4 ± 2.5 μm) (Fig. 1B). These glutamate-evoked transporter currents closely resembled glutamate transporter currents recorded in outside-out patches from astrocytes in hippocampal slices (Bergles and Jahr, 1997, 1998) and from HEK cells expressing EAAT2 transporters (Otis and Kavanaugh, 2000).
A model for transport by GLT-1
A chemical-kinetic model developed to account for the properties of the EAAT3 transporter (A. Tzingounis, personal communication) was adapted to simulate the kinetics of GLT-1-mediated transporter currents (Fig. 2A). This model is based on an alternating access scheme (Läuger, 1991;Kavanaugh, 1998) and incorporates the dependence of glutamate transport on Na+, K+, and H+ as well as transmembrane voltage. The permeability to anions, in physiological conditions, is accounted for primarily by anion conducting states directly connected to three states in the cycle: ToNa2H, ToNa3GH, and TiK (although very minor components of the conductance were from open states connected to the other Na+-bound external states) (Fig.2B). In the absence of substrate, glutamate transporters exhibit a “leak” conductance to anions that is shut off by antagonists such as kainate, dihydrokainate (Bergles and Jahr, 1997; Otis and Jahr, 1998), andd,l-threo-β-benzyloxyaspartate (TBOA) (see below; Watzke et al., 2001). This standing leak conductance is accounted for by the open state connected to ToNa2H (in addition to a very small component added via ToNa2). With the rapid application of substrate (10 mml-glutamate) to the external face of the transporter, a fast transient anion current is evoked, primarily from the occupancy of the open state attached to ToNa3GH. After several milliseconds a steady-state current is reached that is a combination of occupation of the open states attached to TiK and ToNa3GH; the open state attached to ToNa2H, the main leak conductance, is practically unoccupied during the presence of substrate. At the end of the pulse of substrate the slow return to the leak conductance level is the result of the relatively slow deoccupation of TiK because of the rate-limiting, potassium-dependent translocation step. Were it not for the TiK open state, an apparent outward current, relative to the resting leak, is produced at the end of the substrate application. This outward current is actually the result of a decreased occupancy of all anion conductance states, below that observed at rest. Such a current is seen in patch recordings from hippocampal astrocytes (Bergles and Jahr, 1997) and Purkinje cells (Otis and Jahr, 1998); however, it was not observed in EAAT2 (Otis and Kavanaugh, 2000) or in the current study of GLT-1. The lack of this “overshooting” decrease in anion conductance requires a compensating open state that precedes the rate-limiting step, which in the present model is served by the TiK open state. As shown in Figure2C, this model mimics the peak and steady-state dose–response curves of the anion currents through GLT-1 (Fig. 1).
Comparison of coupled versus uncoupled transporter currents
To determine the relationship between the anion current associated with glutamate transport (Fairman et al., 1995; Wadiche et al., 1995a) and the current produced by the movement of charges stoichiometrically linked to transport, we recorded glutamate transporter currents in the absence of permeant anions in the intracellular solution. Transporter currents recorded with internal gluconate (K+ salt), which does not permeate the transporter-associated anion channel (Wadiche et al., 1995a; Eliasof and Jahr, 1996; Wadiche and Kavanaugh, 1998), were smaller (peak amplitude, −28.5 ± 2.0 pA; n = 16) and exhibited faster kinetics (rise time, 138 ± 8 μsec; half-decay time, 860 ± 41 μsec) than currents recorded with the permeant anion thiocyanate (Fig. 3A,B). However, the shape of the responses was similar under the two conditions, with the stoichiometric current rising to a peak, decaying to a steady-state level in the continued presence of glutamate, and returning to baseline with a biexponential decay with the removal of glutamate. The ratio of the amplitude measured at steady state to that measured at the peak was similar for both anion and stoichiometric currents (SS/peak ratio: KSCN, 0.10 ± 0.01, n = 20; K-gluconate, 0.15 ± 0.01, n = 16).
The stoichiometric current is accounted for in the model (Fig.3C) by the net flux of transporters through the voltage-dependent steps of Na+ binding to two external states (To and ToNa2GH), Na+ unbinding from the cytoplasmic face (TiNa3GH), and from the return potassium-dependent translocation step (TiK to ToK). The forward translocation step (ToNa3GH to TiNa3GH) is modeled as a voltage-independent transition and thus does not participate in the stoichiometric current. The voltage dependence and the rationale for these assumptions are addressed below.
The slower kinetics of the transporter currents recorded with internal SCN− may indicate that conformational changes associated with charge transfer and anion channel gating were slowed in the presence of this anion. To address this question, we compared the time necessary for the peak amplitude of the response to recover from the steady-state level (paired pulse recovery) in recordings with gluconate as the primary internal anion (Fig.4B) with recordings in which SCN− was the primary internal anion (Fig. 4A). The time constant of recovery was not significantly different for the two conditions (τKSCN = 33.1 ± 0.55 msec,n = 6; τgluconate = 32.5 ± 0.7 msec, n = 10) (Fig. 4C), indicating that internal thiocyanate does not slow down the cycling rate of GLT-1 significantly. The model faithfully reproduces the paired pulse recovery times in both conditions (Fig.5). Because the recovery times were slower than those recorded in patches from astrocytes (Bergles and Jahr, 1997) that express both GLT-1 and GLAST, we reassessed the recovery times in the present study by using a SCN−-based internal solution more similar to that used in the previous study (i.e., without TEA). In the absence of TEA, recovery was speeded by ∼35% (τKSCN−TEA = 21.8 ± 0.8 msec;n = 10) (Fig. 4C, open squares), suggesting that TEA slowed the rate-limiting steps of the cycle. Such a slowing was mimicked in the model by slowing the binding rate of internal K+ from 106 to 104per m/sec and increasing the opening rate from TiK from 55 to 100/sec (τanion+TEA = 29.9 ± 0.4 msec; τstoichiometric = 29.0 ± 0.1 msec; τanion−TEA = 17.6 ± 0.2 msec) (Fig. 5). These data suggest that TEA interferes with the binding of K+ to the internal face of the transporter, as has been reported for the Na+/K+ pump (Eckstein-Ludwig et al., 1998). With the exception of these experiments, TEA was not included in internal solutions used in this study. The model predicts that the anion current (SCN−) has slower kinetics than the stoichiometric current (gluconate) because the open state linked to ToNa3GH is reached after Na+ binds within the membrane field (to ToNa2GH), and this open state is revisited several times, on average, before glutamate unbinds. In the absence of internal TEA, Na+, or glutamate, the model predicts that the cycling rate of GLT-1 is 44/sec, whereas the paired pulse recovery requires 17.6 msec (a rate of 57/sec). The paired pulse recovery rate is faster because some of the bound glutamate is not transported and released into the cytoplasm; instead, glutamate unbinds to the outside, providing a second pathway for recovery. In conditions that may mimic the astrocytic cytoplasm environment more accurately (10 mmNa+, 50 μmglutamate inside; Chatton et al., 2000), the model predicts that the cycling rate will slow to 37/sec (and the paired pulse recovery to 51/sec). Thus at physiological temperature, assuming a Q10 of ∼2–3 (Bergles and Jahr, 1998; Wadiche and Kavanaugh, 1998), the cycling rate of GLT-1 transporters is likely to be ∼10–20 msec.
Internal Cs+ slows counter-transport
Previous studies of transporter currents in isolated retinal Müller cells demonstrated that Cs+could substitute for K+ at the counter-transport site to support glutamate transporter cycling; however, transporter currents elicited with Cs+ in the pipette were only two-thirds as large as those elicited with K+ in the pipette (Barbour and Attwell, 1991). To determine whether Cs+ also supports the cycling of GLT-1, we made a complete substitution of K+ with Cs+ in the internal solution and recorded transporter currents in response to 10 mml-glutamate. Nitrate-based (NO3−) internal solutions were used for these experiments because the Cs+ salt of thiocyanate is not soluble at physiological pH. The peak amplitude of the GLT-1 transporter current recorded with Cs+ was significantly smaller than that recorded with K+(CsNO3: −16.8 ± 2.6 pA, n= 8; KNO3: −49.2 ± 7.3 pA,n = 6; p < 0.0001) (Fig.6A,B). In addition, the steady-state amplitude was reduced nearly to zero with internal Cs+, suggesting that cycling occurs much more slowly with this cation and that anion conducting states are visited infrequently. In support of this conclusion the peak of the transporter current recovered by only 47 ± 5% (n= 6) in 120 msec in Cs+ compared with 105 ± 3% (n = 8) with K+. This is consistent with the effects of Cs+ on the Na+/K+ pump in which Cs+ has a 20-fold lower affinity than K+ (Omay and Schwarz, 1992).
Similar experiments were performed with K-gluconate and Cs-gluconate to determine whether the stoichiometric current exhibited a similar behavior after the replacement of internal K+ with Cs+.l-Glutamate-evoked transporter currents were smaller with Cs-gluconate (−9.72 ± 2.15 pA; n = 6) than with K-gluconate (−28.5 ± 2.0 pA; n = 16), they exhibited a smaller steady-state current, and they cycled more slowly (paired pulse recovery at 120 msec: Cs-gluconate, 52 ± 4%,n = 4; K-gluconate, 104 ± 2%, n= 4) (Fig. 6E,F), similar to the effects observed on the anion-potentiated transporter currents.
The effects of internal Cs+ could be mimicked in the model by using modifications similar to those used to fit the data recorded with internal TEA. For internal Cs+ the K+binding rate to Ti was slowed to 8 × 103 per m/sec, the translocation rate from TiK to ToK was slowed from 40 to 8/sec, and the opening rate from TiK was increased from 55 to 85/sec. These modifications were sufficient to mimic the kinetic changes of both anion and stoichiometric currents (Figs. 6C,D,7C,D). The model predicts that internal Cs+ will slow the cycling rate to ∼6/sec, over sevenfold slower than with internal K+. Because many physiological studies of synaptic transmission use internal Cs+ to block K+ channels and increase membrane resistance, this action of internal Cs+ on transport could decrease neuronal uptake and alter the strength of synaptic excitation. One deficiency of the model is that it does not predict the more than twofold decrease in the peak of the current seen with internal Cs+. This discrepancy could be accounted for if Cs+, in addition to its effect on the rate of counter-transport, acted as a noncompetitive antagonist, effectively decreasing the pool of available transporters and further diminishing the capacity of uptake.
Internal Na+ blocks counter-transport
The dependence of counter-transport on intracellular K+ (Kanner and Sharon, 1978; Kanner and Bendahan, 1982) suggested that removal of internal K+ would prevent transporter cycling. Substitution of Na+ for internal K+ therefore could isolate the charge movements associated only with the Na+-bound transitions. To investigate this possibility, we replaced K+ with Na+ in the pipette solution (NaSCN). Transporter currents persisted under these conditions but had significantly smaller amplitudes (−110.2 ± 12.6 pA;n = 5) than those recorded with internal K+ (206.2 ± 21.3 pA;n = 20). These currents rose to a peak rapidly (340 ± 16 μsec) but decayed more slowly to a steady-state level (Fig. 7A). Surprisingly, the steady-state current persisted despite the removal of l-glutamate, suggesting that in the absence of internal K+ the transporter continued to visit a conducting state. Recovery of the response was very slow, because the peak response recovered by only 16 ± 3% (n = 5) after 120 msec. Indeed, for these experiments the repetition rate had to be increased from every 5 sec to every 15 sec to allow the transporter current to recovery fully between pulses of glutamate. That the response does recover, albeit slowly, indicates that there is a mechanism by which the transporters can become competent to bind glutamate again, even in the absence of internal K+.
If intracellular concentrations of Na+ and glutamate rise, the transporter is forced to operate in an “exchange mode” (Kanner and Bendahan, 1982; Otis and Jahr, 1998), decreasing the net influx of glutamate and Na+. When 10 mml-glutamate was added to the NaSCN intracellular solution, transporter currents elicited by external glutamate had an amplitude (−142.3 ± 17.0 pA; n= 4) and rise time (320 ± 38 μsec) similar to those recorded with NaSCN alone (Fig. 7B). However, the amplitude of the steady-state response was increased dramatically (SS/peak ratio = 0.73 ± 0.09), as expected if transporters are forced to enter a conducting state repeatedly. With the removal of extracellular l-glutamate this current decayed with a τ of 35.6 ± 4.3 msec (single exponential fit) compared with the biexponential fit (τ1 = 1.36 ± 0.11 msec, 74%; τ2 = 21.94 ± 2.1 msec) observed with K+ inside. The slow decay of this current may, in part, reflect the relatively slow unbinding of glutamate to the outside (see below). However, this decay was strongly voltage-dependent and became faster at more depolarized potentials (data not shown), indicating a voltage-dependent transition in the path to unbinding. The ability of intracellular glutamate to force unbinding to the outside allowed the peak of the transporter current to recover by 96 ± 4% in 120 msec (n = 4).
The behavior of the stoichiometric current was analyzed under similar conditions. Application of glutamate to patches with Na-gluconate inside elicited transient inward currents (Fig. 7E). As with Cs-gluconate, these responses were significantly smaller than those recorded with K+ inside (peak amplitude, −6.8 ± 2.5 pA; n = 5). In contrast to the responses recorded with SCN−, transporter currents recorded under these conditions decayed to almost zero, suggesting that internal Na+ does not support cycling readily. Consistent with this hypothesis, the peak amplitude recovered by only 20 ± 4% in 120 msec, similar to that observed with NaSCN. The addition of 10 mmglutamate to the Na-gluconate solution did not change the size of the peak response to 10 mm external glutamate significantly (peak amplitude, −21.2 ± 12.0 pA;n = 3) (Fig. 7F); however, as seen for NaSCN, this manipulation accelerated the recovery from steady state such that the peak amplitude now recovered by 91 ± 7% at 120 msec.
The model reproduces the effects of substituting internal K+ with Na+(Fig. 7C,D). In the absence of internal glutamate the model predicts that transporters will accumulate into internal Na+-bound states. As transporters collect inside, the anion current disappears unless a conducting state can be visited from the inside. The sustained anion current evoked in these conditions is reproduced well by the conducting state reached from TiNa2, the first internal state reached in the cycle that is not bound by glutamate. The accumulation of transporters in internal states is reversible, because ∼20% of the current does recover after 120 msec (Fig.8). The model can mimic this slow recovery in two ways, either by having a slow transition between TiNa2 and ToNa2 or by allowing internal Na+ to substitute for the normally K+-driven translocation. Although the present data do not distinguish between these two possibilities, the latter possibility has been depicted in the model (Fig.2A). The addition of internal glutamate forces the transporter into an exchange mode, continually revisiting the Na+ and glutamate-bound internal and external states. Because the open state attached to ToNa3GH is occupied repeatedly in this condition, a large steady-state current is achieved. When external glutamate is withdrawn, the relatively slow glutamate unbinding rate to the outside forces the transporter to exchange a few times before glutamate unbinds at the external face. This slow relaxation is responsible for the relatively slow decay of the anion current at the end of the glutamate pulse. The voltage dependence of this decay is the result of the voltage dependence of the binding and unbinding of the third Na+, which precedes external glutamate unbinding.
The stoichiometric currents recorded with Na-gluconate-based internal solutions can be replicated by this model without further modifications (Fig. 7G,H). In the absence of internal glutamate the transporters accumulate in internal states, and no steady-state current is seen, reflecting a lack of cycling through the K+ counter-transport transition. In the presence of internal glutamate, after an initial transient net influx, again the steady state is nonexistent as cycling is reduced to zero through the K+ counter-transport transition.
Voltage dependence of transport
The uptake of glutamate by GLT-1 is strongly voltage-dependent (Wadiche et al., 1995b; Levy et al., 1998). We examined the voltage dependence of GLT-1 transporter currents by applying 10 mml-glutamate to patches held at range of potentials between −100 and 50 mV. The current to voltage (I–V) relationship of the peak of the response exhibited prominent inward rectification, and transporter currents did not reverse at potentials as positive as 50 mV (Fig. 8A,C). A similar rectification of peak currents was observed with recordings in the absence of permeant anions (K-gluconate internal solution) (Fig.8B,C). The model accounts for the voltage dependence of transport by assigning voltage dependence to the first and third Na+ binding step to the external face of the transporter, the unbinding step of the first Na+ after translocation (TiNa3GH to TiNa2GH), and the K+-dependent translocation (A. Tzingounis, personal communication). In addition, the voltage dependencies of the internal Na+ binding step and the K+-dependent translocation are asymmetrical. These asymmetries are required to mimic the kinetics of the currents across the range of holding potentials that were tested.
In the previous figures anion currents are simulated as open probabilities (Po). However, when different holding potentials are compared, thePo should be scaled according to the electrochemical gradient and the voltage dependence of the anion conductances. Unfortunately, we have not been able to measure the voltage dependence of the anion conductances independently ofPo. We have measured theI–V relationship of the substrate-independent anion leak current, as described below. If we assume that the voltage dependence of the conductance states activated by glutamate is the same as that of the leak current, we can scale the simulatedPo traces by using the I–Vrelationship obtained for the leak current. When this scaling is performed, however, the simulated voltage dependence of glutamate-evoked anion currents is far too great, suggesting that the voltage dependence of the leak current is not the same as that for glutamate-evoked conductances. The simulations (Fig.8D,F), therefore, are presented as the unaltered Po.
Pharmacological inhibition of transporter currents
EAAT2 transporters are inhibited by the nontransported antagonist dihydrokainate (DHK) with a Ki of between 24 and 79 μm (Arriza et al., 1994;Shimamoto et al., 1998), an affinity 100-fold greater than that for other glutamate transporters. In the presence of permeant anions (SCN− internal) DHK alone produced an outward shift in the holding current (Fig.9A), consistent with observations made in patches from astrocytes (Bergles and Jahr, 1997) and from HEK cells expressing EAAT2 (Otis and Kavanaugh, 2000). This outward shift suggests that there is a leak of anions through the transporters that is maintained in the absence of glutamate and blocked by DHK. The voltage dependence of the DHK-induced responses was the inverse of that observed for l-glutamate (Fig.9B), as expected if these responses were mediated by an inhibition of a resting anion current. With the removal of DHK the current returned to baseline with a τ of 23.2 ± 2.8 msec (n = 4; single exponential fit). This decay provides an estimate for the unbinding rate of DHK, if it is assumed that the conductance opens without delay after the unbinding of DHK. The application of TBOA (300 μm), a nontransported antagonist that has an ∼10-fold higher affinity for EAAT2 (Ki = 5.7 μm;Shimamoto et al., 1998), produced a similar maximal shift in the holding current but decayed with a τ of 247.2 ± 20.4 msec (n = 4; single exponential fit) with removal, indicating that TBOA unbinds much more slowly than DHK from GLT-1 transporters (Fig. 9A). It was possible to model these decays by setting the unbinding rate of DHK as 165/sec and the unbinding rate of TBOA as 6/sec (Fig. 9C).
We examined the kinetics of inhibition of GLT-1 by DHK by measuring the effect of 300 μm DHK on the response to a saturating dose of l-glutamate (10 mm). As expected from the results above, DHK alone produced an outward shift in the holding current. In addition, DHK inhibited the peak, but not the steady-state current, in response to l-glutamate (Fig.10A); presumably, 10 mm glutamate is sufficient to overwhelm this competitive antagonist at steady state despite a high occupancy by DHK in the absence of glutamate. In the absence of permeant anions (K-gluconate internal) DHK (300 μm) also inhibited the peak of the response to l-glutamate (10 mm) (Fig. 10B). However, as expected because of the absence of permeant anions and thus the leak current, DHK produced no outward shift in the holding current.
The major features of inhibition of both anion and stoichiometric currents by DHK were reproduced by the model (Fig. 10C,D). The predicted microscopic affinity for DHK is 55 μm (on rate = 3 × 106 per m/sec; off rate = 165/sec), a value in the range measured experimentally for EAAT2 [Arriza et al. (1994), Ki = 23 μm; Shimamoto et al. (1998), IC50 = 196 μm].
Agonist-dependent changes in kinetics
Different excitatory amino acids have been shown to elicit transporter currents with dramatically different kinetics (Bergles and Jahr, 1997; Wadiche and Kavanaugh, 1998), in part because of the different affinities of the transporters for different agonists (Arriza et al., 1994). In particular, transporter currents in outside-out patches recorded from oocytes expressing EAAT1 transporters (Wadiche and Kavanaugh, 1998), from astrocytes (Bergles and Jahr, 1997), and from Bergmann glial cells (Bergles et al., 1997) exhibited much slower kinetics in response to aspartate than to glutamate. Unexpectedly, the kinetics of GLT-1 in response to l-glutamate andd-aspartate were very similar (data not shown), and the amplitudes of the steady-state currents were not significantly different (paired t test) (l-glutamate, −19.4 ± 3.3 pA;d-aspartate, −19.6 ± 3.7 pA;n = 15). However, with permeant anions the peak amplitude of d-aspartate currents was 66 ± 1% (n = 15) of l-glutamate, resulting in a significantly larger SS/peak ratio (d-aspartate, 0.22 ± 0.02;l-glutamate, 0.12 ± 0.01; n= 15). In addition, d-aspartate-evoked currents decayed more slowly at the end of the pulse. Coupled transporter currents recorded with internal K-gluconate exhibited the same features; the peak amplitude of responses tod-aspartate was 79 ± 3% (n= 12) of the l-glutamate response (data not shown), although the steady-state amplitudes were not significantly different (paired t test) (l-glutamate, −3.5 ± 0.5 pA;d-aspartate, −3.5 ± 0.4 pA;n = 12). These differences can be simulated, at least qualitatively, if the binding and unbinding rates ofd-aspartate are slowed relative tol-glutamate, the forward translocation rate is decreased by 35%, and the opening rate of the conductance from the fully bound state (ToNa3GH) is approximately halved. The slowed translocation rate is in line with the observed lower flux rate of d-aspartate thanl-glutamate through EAAT2 (Imaxd-aspartate/Imaxl-glutamate = 0.84; Arriza et al., 1994). However, the lack of difference between steady-state stoichiometric currents indicates that in these conditions the uptake of the two substrates should be similar. Indeed, the model predicts that the cycling rate achieved with an application of 10 mmd-aspartate is also 42/sec, indicating that for d-aspartate transport the K+ counter-transport transition is similarly rate-limiting.
DISCUSSION
The translocation of glutamate by the Na+-dependent glutamate transporters is associated with net movement of positive charge through the membrane field. This unbalanced stoichiometry results from the movement of 3 Na+, 1 H+into the cell with each negatively charged molecule of glutamate and only 1 K+ out (Zerangue and Kavanaugh, 1996; Levy et al., 1998). In addition to this movement of cations essential for glutamate translocation and transporter cycling, glutamate transporters also allow anions to flow across the membrane (Fairman et al., 1995; Wadiche et al., 1995a; Eliasof and Jahr, 1996). In this study we used a heterologous expression system (Dunlop et al., 1999) to create a high density of GLT-1 transporters in the plasma membrane so that the kinetic properties of both the stoichiometric and anion currents associated with glutamate uptake could be recorded in outside-out patches. These studies revealed that the kinetics of the anion currents are slower than stoichiometric currents but that anions do not alter appreciably the recovery rate or the efficiency of GLT-1 transporters. We developed a chemical-kinetic model that mimics the behavior of GLT-1, in which the anion conductance is associated with multiple states in the cycle and the rate-limiting transition occurs during the counter-transport of K+ (Kanner and Sharon, 1978; Kanner and Bendahan, 1982).
Relationship between stoichiometric and anion currents
Although transporter currents recorded with and without permeant anions had similar waveforms, the stoichiometric current rose faster and decayed more rapidly from the peak than the anion current, as shown previously for astrocyte transporters (Bergles and Jahr, 1997), for EAAC1 (Grewer et al., 2000; Watzke et al., 2001), and for Purkinje cell transporters (Auger and Attwell, 2000; Wadiche and Jahr, 2001). However, the slower kinetics of the anion-potentiated transporter currents were not translated into a slower overall paired pulse recovery rate of GLT-1, suggesting that states in the transport cycle are occupied for similar periods whether or not permeable anions are present. The slower time course of the anion currents suggests that conducting states are reached, and can be revisited, subsequent to the movement of coupled charges through the membrane field. More dramatic differences in the kinetics of anion and stoichiometric currents were observed when internal K+ was substituted with Na+. With permeant anions inside (NaSCN-based internal solution), the current remained active long after glutamate removal, whereas in the absence of permeant anions (Na-gluconate-based internal solution) the stoichiometric current decayed to zero. When Na+ is the only internal cation, external glutamate causes transporters to accumulate in Na+-bound internal states that conduct anions. The lack of a steady-state component of the stoichiometric current indicates that cycling occurs only very slowly in this condition. Similarly, internal Cs+substitution also dramatically slowed cycling, indicating that Cs+ is inefficient at supporting counter-transport. It is possible that anions also slow transitions between some states in the transport cycle, as suggested by Auger and Attwell (2000) for Purkinje cell glutamate transporters. However, such an effect would have to be small compared with the rate-limiting K+ counter-transport step, because anions affect neither paired pulse recovery (Fig. 4) nor glutamate flux in steady-state conditions (Wadiche et al., 1995a).
Efficiency of transport by GLT-1
An important parameter of transport is the probability that the binding of a molecule of substrate to the external face of the transporter leads to release of a molecule of substrate into the cytoplasm (i.e., transport) rather than back into the extracellular space. If substantial extracellular unbinding occurs in physiological conditions, glutamate will have the opportunity to bind to receptors long after release, although transporters still could lower the concentration of glutamate in the extracellular space rapidly and slow diffusion through buffering (Rusakov and Kullmann, 1998;Diamond, 2001) (but see Barbour, 2001). We have estimated the efficiency of this transporter by simulating a very short (1 μsec) application of glutamate and measuring the net flux through the unbinding transitions to either the internal and external faces. The ratio of unbinding to the inside to the sum of unbinding on both sides provides a measure of the efficiency of the transporter. Under the conditions used for the majority of the experiments in this study (0 glutamate, 0 Na+ internal), the predicted efficiency of GLT-1 is 65%. This value is particularly sensitive to the unbinding rate of glutamate to the outside, a rate that unfortunately is not well defined. The dose–response relationship (Fig. 1), for instance, can be simulated reasonably well with off rates ranging from 250 to 1000/sec; however, the estimate of efficiency changes from 79 to 48%, respectively, over this range. If we use an unbinding rate of 500/sec, changing the internal composition to one that may be more representative of astrocyte cytoplasm (10 mm Na+, 50 μmglutamate) had little effect on efficiency (64%), whereas decreasing the holding potential from −90 to −60 mV lowered the efficiency to 50%. Increasing internal glutamate to 10 mm further decreased the efficiency to 44%. Under these conditions efficiency becomes the probability that there will be a net flux of one glutamate molecule from the outside to the inside per cycle; when glutamate and Na+ are present internally, the translocation of one molecule of glutamate from outside to inside can be followed by the reverse translocation of glutamate from the cytoplasm to the extracellular fluid, thereby decreasing efficiency. These results indicate that many transporters function as buffers only, rather than as unidirectional transporters that force the net accumulation of glutamate.
Comparison of GLT-1 to astroglial transporter currents
GLT-1 (EAAT2) is the predominant glutamate transporter in the mammalian brain (Rothstein et al., 1994; Lehre et al., 1995) and is essential for maintaining a low ambient level of glutamate (Rothstein et al., 1996; Tanaka et al., 1997). This transporter is expressed at a high density in astrocyte membranes (Lehre et al., 1995), a density sufficient to allow electrogenic transporter currents to be resolved in outside-out patches from these cells in acute brain slices (Bergles and Jahr, 1997, 1998). GLT-1 transporter currents evoked byl-glutamate exhibited many of the same characteristics as those recorded in patches from astrocytes, including a rapid rise to a peak, a decay to a steady-state level in the continued presence ofl-glutamate that was ∼10% of the peak amplitude, and an EC50 at steady state that was ∼13 μm. This is in close agreement with the equilibriumKm measurements made from GLT-1 expressed in Chinese hamster ovary cells (16.5 μm;Levy et al., 1998). In addition, both GLT-1 and astrocyte transporter currents were ∼10-fold larger when recorded in the presence of SCN− in the internal solution, consistent with the high permeability of these transporters to chaotropic anions (Wadiche et al., 1995a). GLT-1 transporters also exhibited a substrate-independent leak of anions that could be blocked by the nontransported antagonists DHK and TBOA. However, GLT-1 transporter currents exhibited a slower rise time, a slower decay time in the continued presence of l-glutamate, and a prominent biexponential decay after the removal ofl-glutamate. This trend toward slower kinetics differs from that observed for the EAAT2 transporter recorded in patches from HEK cells, which had somewhat faster initial kinetics than those observed here (Otis and Kavanaugh, 2000). These differences are somewhat surprising given the high sequence homology between EAAT2 and GLT-1 (Kanner, 1993; Arriza et al., 1994). However, a similar biexponential decay after the removal of glutamate was reported for EAAT2 transporters (Otis and Kavanaugh, 2000).
A dramatic difference between GLT-1 and astrocyte transporter currents was observed in the kinetics of the response tod-aspartate (Fig. 7D) (Bergles and Jahr, 1997).d-Aspartate-evoked transporter currents from astrocytes exhibited a prominent steady-state component that was not observed with GLT-1 (SS/peak ratio: GLT-1, 0.22 ± 0.02; astrocyte, 0.52 ± 0.15). This difference may reflect the presence of GLAST glutamate transporters that also are expressed in hippocampal astrocytes (Rothstein et al., 1994; Lehre et al., 1995), because transporter currents mediated by EAAT1, the human homolog of GLAST, exhibit an enhanced steady-state current in response tod-aspartate (Wadiche and Kavanaugh, 1998) and transporter currents recorded from Bergmann glial cells, which express a high density of GLAST transporters (Rothstein et al., 1994; Lehre et al., 1995), exhibit a large steady-state current in response tol-aspartate (Bergles et al., 1997). These observations are consistent with the complete inhibition of the peak amplitude of GLT-1 transporter currents by DHK (Fig. 10), an antagonist with a >100-fold higher affinity for EAAT2 than for EAAT1 transporters (Arriza et al., 1994), but only a partial inhibition of the peak amplitude of astrocyte transporter currents [Bergles and Jahr (1997), their Fig. 6E].
The ability to record both stoichiometric charge movement and anion permeation mediated by GLT-1 has allowed for the creation of a kinetic model of transport that reproduces both coupled and uncoupled currents measured experimentally. The model has been used to estimate the efficiency of glutamate transport and rates of cycling in a variety of conditions those parameters of transport that have not been amenable to direct experimental determination. These characteristics of transport may be critical in determining the activation of glutamate receptors both within and surrounding the synaptic cleft after exocytotic release and during pathological conditions such as ischemia.
Footnotes
This work was supported by grants from the National Institutes of Health (NS21419 and NS40056 to C.E.J.), the Human Frontier Science Program (RG 119/2000 to C.E.J.), and the ALS Association (to D.E.B.). We thank Dr. Keiko Shimamoto for supplying TBOA, Dr. John Dunlop and Wyeth-Ayerst Research for providing the GLT-1-expressing cell line, and Drs. Michael Kavanaugh and Jacques Wadiche for valuable discussions throughout this project.
Correspondence should be addressed to Craig Jahr, Vollum Institute, Oregon Health and Science University, L474, 3181 South West Sam Jackson Park Road, Portland, OR 97201-3098. E-mail: jahr{at}ohsu.edu.
D. E. Bergles' present address: Department of Neuroscience, Johns Hopkins University School of Medicine, 725 North Wolfe Street, WBSB 813, Baltimore, MD 21205.